Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sechter

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Therapie|January 1, 1997
Observations of the interaction between tricyclic antidepressants and fluvoxamine in poor metabolizers of dextromethorphan and mephenytoinP Vandel, B Bonin, G Bertschy, et al.
L'Encephale|June 1, 1997
[Indications for electroconvulsive therapy]J Boiteux, L Roubaud, N Gandelet, et al.
Pharmacological Research|June 1, 1995
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patientsS Vandel, G Bertschy, P Baumann, et al.
L'Encephale|May 1, 1996
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]B Bonin, G Bertschy, P Baumann, et al.
Neuropsychobiology|January 1, 1992
Tricyclic antidepressant plasma levels after fluoxetine additionS Vandel, G Bertschy, B Bonin, et al.
Psychopharmacology|January 1, 1986
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsM F Poirier, C Benkelfat, H Loo, et al.
Therapeutic Drug Monitoring|December 29, 2000
Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluationM Gex-Fabry, E Haffen, G Paintaud, et al.
Revue D'Epidemiologie Et De Sante Publique|January 26, 2006
[Neuroleptic drug utilization among schizophrenic outpatients]P Blin, J-P Olié, D Sechter, et al.
Therapie|January 1, 1995
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]P Vandel, P Bizouard, S Vandel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1994
Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophreniaJ M Leroux, E Elia, M Jacquet, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Therapie|January 1, 1997
Observations of the interaction between tricyclic antidepressants and fluvoxamine in poor metabolizers of dextromethorphan and mephenytoinP Vandel, B Bonin, G Bertschy, et al.
L'Encephale|June 1, 1997
[Indications for electroconvulsive therapy]J Boiteux, L Roubaud, N Gandelet, et al.
Pharmacological Research|June 1, 1995
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patientsS Vandel, G Bertschy, P Baumann, et al.
L'Encephale|May 1, 1996
[Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]B Bonin, G Bertschy, P Baumann, et al.
Neuropsychobiology|January 1, 1992
Tricyclic antidepressant plasma levels after fluoxetine additionS Vandel, G Bertschy, B Bonin, et al.
Psychopharmacology|January 1, 1986
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsM F Poirier, C Benkelfat, H Loo, et al.
Therapeutic Drug Monitoring|December 29, 2000
Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluationM Gex-Fabry, E Haffen, G Paintaud, et al.
Revue D'Epidemiologie Et De Sante Publique|January 26, 2006
[Neuroleptic drug utilization among schizophrenic outpatients]P Blin, J-P Olié, D Sechter, et al.
Therapie|January 1, 1995
[Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital]P Vandel, P Bizouard, S Vandel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1994
Correlation of clinical response (PANSS) and plasma levels of haloperidol and reduced haloperidol in schizophreniaJ M Leroux, E Elia, M Jacquet, et al.
Pageof 9